Mutual of America Capital Management’s Trupanion TRUP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,342
Closed -$240K 1402
2025
Q2
$240K Buy
+4,342
New +$192K ﹤0.01% 1256
2025
Q1
Sell
-5,068
Closed -$244K 1449
2024
Q4
$244K Buy
5,068
+58
+1% +$2.98K ﹤0.01% 1328
2024
Q3
$210K Buy
+5,010
New +$195K ﹤0.01% 1382
2023
Q2
Sell
-7,241
Closed -$311K 1497
2023
Q1
$311K Sell
7,241
-128
-2% -$6.92K ﹤0.01% 1269
2022
Q4
$350K Buy
7,369
+398
+6% +$20.7K ﹤0.01% 1216
2022
Q3
$414K Buy
6,971
+1,159
+20% +$77.8K 0.01% 1156
2022
Q2
$350K Buy
5,812
+867
+18% +$59K ﹤0.01% 1167
2022
Q1
$441K Buy
4,945
+257
+5% +$23.6K ﹤0.01% 1138
2021
Q4
$619K Buy
4,688
+128
+3% +$14.9K 0.01% 1090
2021
Q3
$354K Sell
4,560
-224
-5% -$22.1K ﹤0.01% 1190
2021
Q2
$551K Buy
4,784
+355
+8% +$30.9K 0.01% 1131
2021
Q1
$338K Buy
4,429
+347
+9% +$35.6K ﹤0.01% 1224
2020
Q4
$489K Buy
4,082
+151
+4% +$14.3K 0.01% 1110
2020
Q3
$310K Buy
+3,931
New +$236K ﹤0.01% 1140

Other funds holding TRUP

Mutual of America Capital Management's TRUP Position: Q3 2025 in Review

Mutual of America Capital Management sold out of Trupanion (TRUP) in Q3 2025, closing a stake of 4,342 shares — an estimated $240K sold.

Mutual of America Capital Management first reported a position in TRUP in Q3 2020 and held it in 14 quarters. The position peaked at $619K in Q4 2021. 221 funds tracked by Wall St. Rank hold TRUP as of Q3 2025.

  • Mutual of America Capital Management reported no remaining Trupanion position as of Q3 2025 after selling out during the quarter.
  • Mutual of America Capital Management sold 4,342 Trupanion shares in Q3 2025, an estimated $240K.
  • Mutual of America Capital Management first reported a position in Trupanion in Q3 2020 and held it in 14 quarters.
  • Mutual of America Capital Management's Trupanion position peaked at $619K in Q4 2021.
  • 221 funds tracked by Wall St. Rank held Trupanion as of Q3 2025.

Based on Mutual of America Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.